Ferrero Irene, Dewilde Sarah, Poletti Paolo, Canepa Barbara, Giachino Enrica, Dall'Ara Paola, Filipe Joel
Agrolabo S.p.A., 10010 Scarmagno, Italy.
Gem Forlab S.r.l., 10014 Caluso, Italy.
Vet Sci. 2025 Mar 4;12(3):245. doi: 10.3390/vetsci12030245.
BACKGROUND/OBJECTIVES: Feline coronavirus (FCoV) belongs to the family Coronaviridae and includes two pathotypes, the less virulent feline enteric coronavirus (FECV), which replicates in the enteric epithelial cells, and feline infectious peritonitis virus (FIPV), which is more virulent, replicates efficiently within monocytes/macrophages with systemic involvement and may cause feline infectious peritonitis (FIP), a progressive and often fatal disease. The diagnosis of FIP is complex and requires different examinations. Among serological tests, the indirect immunofluorescent antibody test (IFAT), considered the gold standard, and the enzyme-linked immunosorbent assay (ELISA) are the most widely used to detect FCoV antibodies. The aim of this work was the development of FCoVCHECK Ab ELISA, a new rapid indirect test for the detection of FCoV antibodies in feline serum/plasma samples.
FCoVCHECK Ab ELISA was developed after a meticulous set-up and cut-off analysis through several methods, including the Youden's index and ROC curve, to achieve the best test performance. It was validated by testing 110 feline sera (62 positives and 48 negatives) against the reference IFAT and compared with two other rapid ELISA tests, INgezim Corona Felino (Gold Standard Diagnostics) and ImmunoComb Feline Coronavirus (FCoV) [FIP] Antibody Test Kit (Biogal).
FCoVCHECK Ab ELISA agreed with IFAT at 96.4% (93.5% sensitivity, 95% confidence interval (CI): 83.5-97.9%; 100% specificity, 95% CI: 90.8-100%), with ImmunoComb FCoV at 93.6% and with INgezim Corona Felino at 82.7%. Intra- and inter-assay accuracy and precision gave coefficients of variation lower than 20%. Compared to IFAT, the new assay correctly identifies positive and negative samples with a good correlation, and, in addition, it is simpler, faster and provides a less subjective reading of the results.
背景/目的:猫冠状病毒(FCoV)属于冠状病毒科,包括两种致病型,即致病性较低的猫肠道冠状病毒(FECV),它在肠道上皮细胞中复制;以及猫传染性腹膜炎病毒(FIPV),其致病性更强,能在单核细胞/巨噬细胞内高效复制并累及全身,可能导致猫传染性腹膜炎(FIP),这是一种渐进性且往往致命的疾病。FIP的诊断很复杂,需要进行不同的检查。在血清学检测中,间接免疫荧光抗体试验(IFAT)被视为金标准,酶联免疫吸附测定(ELISA)是检测FCoV抗体最广泛使用的方法。这项工作的目的是开发FCoVCHECK Ab ELISA,这是一种用于检测猫血清/血浆样本中FCoV抗体的新型快速间接检测方法。
通过包括约登指数和ROC曲线在内的多种方法进行细致的设置和临界值分析后,开发出了FCoVCHECK Ab ELISA,以实现最佳检测性能。通过针对参考IFAT检测110份猫血清(62份阳性和48份阴性)对其进行验证,并与另外两种快速ELISA检测方法,即INgezim Corona Felino(金标准诊断公司)和ImmunoComb猫冠状病毒(FCoV)[FIP]抗体检测试剂盒(Biogal)进行比较。
FCoVCHECK Ab ELISA与IFAT的符合率为96.4%(敏感性93.5%,95%置信区间(CI):83.5 - 97.9%;特异性100%,95% CI:90.8 - 100%),与ImmunoComb FCoV的符合率为93.6%,与INgezim Corona Felino的符合率为82.7%。批内和批间的准确性和精密度的变异系数低于20%。与IFAT相比,新检测方法能很好地关联正确识别阳性和阴性样本,此外,它更简单、快速,且对结果的判读主观性更小。